Fig. 3: Success rate of ICS withdrawal in participating practices.

*moderate exacerbation defined as a sustained worsening of respiratory status that requires treatment with systemic corticosteroids and/or antibiotics, COPD chronic obstructive pulmonary disease, ICS inhaled corticosteroids.